Product
VX-407
1 clinical trial
1 indication
Clinical trial
A Phase 1, Randomized, Double-blind, Placebo-controlled, First-in-human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of VX-407 in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2025-04-01